跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 584 条关于
“Mineralys”
全部
584
临床试验
548
药物
3
机构
14
资讯
19
去年
Mineralys Therapeutics' Lorundrostat Advances to Phase 2 for Obstructive Sleep Apnea and Hypertension
去年
Mineralys Therapeutics Completes Enrollment in Lorundrostat Hypertension Trials, Anticipates 2025 Data
去年
Mineralys Therapeutics Completes Enrollment in Lorundrostat Phase 3 Hypertension Trial Ahead of Schedule
去年
Mineralys Therapeutics Secures $175 Million in Public Offering to Advance Aldosterone Inhibitor for Cardiorenal Diseases
9个月前
Mineralys Therapeutics' Lorundrostat Trial Recognized in JAMA's Inaugural "Research of the Year" for Treatment-Resistant Hypertension
去年
Precigen's Papzimeos Becomes First FDA-Approved Treatment for Rare Respiratory Disease
10个月前
Abivax Phase III Success Triggers 850% Stock Surge, Reignites European Biotech Rally
6个月前
R1 Therapeutics Launches with $77.5M to Develop Novel Kidney Disease Treatment
10个月前
Beacon Biosignals Secures $86M Series B to Advance AI-Driven Brain Health Diagnostics
去年
Novel Drug Lorundrostat Shows Significant Promise for Uncontrolled Hypertension in Phase 2b Trial
第 1 页,共 2 页
上一页
下一页